Hare Ian, Gencheva Marieta, Evans Rebecca, Fortney James, Piktel Debbie, Vos Jeffrey A, Howell David, Gibson Laura F
Alexander B. Osborn Hematopoietic Malignancy and Transplantation Program of the West Virginia University Cancer Institute, Robert C. Byrd Health Sciences Center, West Virginia University School of Medicine, Morgantown, WV 26506, USA; Department of Microbiology, Immunology and Cell Biology, Robert C. Byrd Health Sciences Center, West Virginia University School of Medicine, Morgantown, WV 26506, USA.
Alexander B. Osborn Hematopoietic Malignancy and Transplantation Program of the West Virginia University Cancer Institute, Robert C. Byrd Health Sciences Center, West Virginia University School of Medicine, Morgantown, WV 26506, USA.
Stem Cells Int. 2016;2016:8270464. doi: 10.1155/2016/8270464. Epub 2016 Jan 6.
Mesenchymal stem cells (MSCs) are of interest for use in diverse cellular therapies. Ex vivo expansion of MSCs intended for transplantation must result in generation of cells that maintain fidelity of critical functions. Previous investigations have identified genetic and phenotypic alterations of MSCs with in vitro passage, but little is known regarding how culturing influences the ability of MSCs to repair double strand DNA breaks (DSBs), the most severe of DNA lesions. To investigate the response to DSB stress with passage in vitro, primary human MSCs were exposed to etoposide (VP16) at various passages with subsequent evaluation of cellular damage responses and DNA repair. Passage number did not affect susceptibility to VP16 or the incidence and repair kinetics of DSBs. Nonhomologous end joining (NHEJ) transcripts showed little alteration with VP16 exposure or passage; however, homologous recombination (HR) transcripts were reduced following VP16 exposure with this decrease amplified as MSCs were passaged in vitro. Functional evaluations of NHEJ and HR showed that MSCs were unable to activate NHEJ repair following VP16 stress in cells after successive passage. These results indicate that ex vivo expansion of MSCs alters their ability to perform DSB repair, a necessary function for cells intended for transplantation.
间充质干细胞(MSCs)在多种细胞治疗中具有应用价值。用于移植的MSCs体外扩增必须产生能维持关键功能保真度的细胞。先前的研究已确定MSCs在体外传代时会发生基因和表型改变,但对于培养如何影响MSCs修复双链DNA断裂(DSB,最严重的DNA损伤)的能力知之甚少。为了研究体外传代时对DSB应激的反应,将原代人MSCs在不同传代时暴露于依托泊苷(VP16),随后评估细胞损伤反应和DNA修复情况。传代次数不影响对VP16的敏感性或DSB的发生率及修复动力学。非同源末端连接(NHEJ)转录本在暴露于VP16或传代时变化不大;然而,同源重组(HR)转录本在暴露于VP16后减少,随着MSCs在体外传代,这种减少会加剧。对NHEJ和HR的功能评估表明,连续传代后的细胞在暴露于VP16应激后,MSCs无法激活NHEJ修复。这些结果表明,MSCs的体外扩增改变了它们进行DSB修复的能力,而DSB修复是用于移植的细胞的一项必要功能。